Cargando…
Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs)
In spite of a major public health burden with increasing prevalence, current osteoarthritis (OA) management is largely palliative with an unmet need for effective treatment. Both industry and academic researchers have invested a vast amount of time and financial expense to discover the first diseasi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128067/ https://www.ncbi.nlm.nih.gov/pubmed/35619876 http://dx.doi.org/10.1177/1759720X221090297 |